Emergence of Fluoroquinolone Resistance in Group B Streptococcal Isolates in Taiwan

Antimicrobial Agents and Chemotherapy
2008.0

Abstract

Of 1,994 group B streptococcal isolates collected, 26 (1.3%) of the isolates were resistant to levofloxacin, and cross-resistance to other fluoroquinolones was observed. The emergence and prevalence of high-level fluoroquinolone resistance in genetically unrelated isolates were linked to the presence of gyrA, parC, and parE triple mutations in each isolate.

Knowledge Graph

Similar Paper

Emergence of Fluoroquinolone Resistance in Group B Streptococcal Isolates in Taiwan
Antimicrobial Agents and Chemotherapy 2008.0
Prevalence, Characteristics, and Molecular Epidemiology of Macrolide and Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae at Five Tertiary-Care Hospitals in Korea
Antimicrobial Agents and Chemotherapy 2007.0
Contributions of the Combined Effects of Topoisomerase Mutations toward Fluoroquinolone Resistance in Escherichia coli
Antimicrobial Agents and Chemotherapy 2007.0
First Characterization of Fluoroquinolone Resistance in Streptococcus suis
Antimicrobial Agents and Chemotherapy 2007.0
Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates
Antimicrobial Agents and Chemotherapy 2009.0
Emergence of Ciprofloxacin-Nonsusceptible Streptococcus pyogenes Isolates from Healthy Children and Pediatric Patients in Portugal
Antimicrobial Agents and Chemotherapy 2010.0
Fluoroquinolone-Resistant Mutants ofBurkholderia cepacia
Antimicrobial Agents and Chemotherapy 2008.0
Interspecies Recombination Occurs Frequently in Quinolone Resistance-Determining Regions of Clinical Isolates of Streptococcus pyogenes
Antimicrobial Agents and Chemotherapy 2008.0
Real-Time PCR Detection of gyrA and parC Mutations in Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2008.0
Fluoroquinolone Resistance in Streptococcus pneumoniae : Area Under the Concentration-Time Curve/MIC Ratio and Resistance Development with Gatifloxacin, Gemifloxacin, Levofloxacin, and Moxifloxacin
Antimicrobial Agents and Chemotherapy 2007.0